Skip to main content

Table 1 Frequency of HLA–DR phenotypes in Japanese patients with autoimmune hepatitis

From: Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis

HLA–DR phenotype Autoimmune hepatitis (n = 132) Control subjects (n = 31973) P–value Odds ratio (95 % Cl)
1 16 (11.9 %) 3645 (11.4 %) 0.795 1.07 (0.63–1.81)
4 80 (59.7 %) 13365 (41.8 %) <0.001 2.14 (1.51–3.04)
7 1 (0.7 %) 239 (0.75 %) 0.622 1.01 (0.14–7.28)
8 38 (28.4 %) 7513 (23.5 %) 0.153 1.32 (0.90–1.92)
9 27 (20.1 %) 8505 (26.6 %) 0.111 0.71 (0.46–1.08)
11 2 (1.5 %) 1644 (5.143 %) 0.092 0.28 (0.07–1.15)
12 8 (6.0 %) 3485 (10.9 %) 0.100 0.53 (0.26–1.08)
13 14 (10.4 %) 4029 (12.6 %) 0.577 0.82 (0.44–1.43)
14 25 (18.7 %) 4348 (13.6 %) 0.074 1.48 (0.96–2.30)
15 34 (25.4 %) 10647 (33.3 %) 0.066 0.69 (0.47–1.03)
16 3 (2.2 %) 575 (1.8 %) 0.935 1.27 (0.40–4.00)
17 1 (0.7 %) 88 (0.28 %) 0.824 2.77 (0.38–20.0)
6 *1 3 (2.2 %)   
  1. *1 Defined as DR6 before DR6 was further split into DR13 and DR14
  2. Bold-faced type shows statistically significant difference